A single regulator NrtR controls bacterial NAD+ homeostasis via its acetylation
Abstract
Nicotinamide adenine dinucleotide (NAD+) is an indispensable cofactor in all domains of life, and its homeostasis must be regulated tightly. Here we report that a Nudix-related transcriptional factor, designated MsNrtR (MSMEG_3198), controls the de novo pathway of NAD+biosynthesis in M. smegmatis, a non-tuberculosis Mycobacterium. The integrated evidence in vitro and in vivo confirms that MsNrtR is an auto-repressor, which negatively controls the de novo NAD+biosynthetic pathway. Binding of MsNrtR cognate DNA is finely mapped, and can be disrupted by an ADP-ribose intermediate. Unexpectedly, we discover that the acetylation of MsNrtR at Lysine 134 participates in the homeostasis of intra-cellular NAD+ level in M. smegmatis. Furthermore, we demonstrate that NrtR acetylation proceeds via the non-enzymatic acetyl-phosphate (AcP) route rather than by the enzymatic Pat/CobB pathway. In addition, the acetylation also occurs on the paralogs of NrtR in the Gram-positive bacterium Streptococcus and the Gram-negative bacterium Vibrio, suggesting that these proteins have a common mechanism of post-translational modification in the context of NAD+ homeostasis. Together, these findings provide a first paradigm for the recruitment of acetylated NrtR to regulate bacterial central NAD+ metabolism.
https://doi.org/10.7554/eLife.51603.001Introduction
Nicotinamide adenine dinucleotide (NAD+) is an indispensable cofactor of energy metabolism in all domains of life. It not only acts as an electron carrier in redox reactions (Belenky et al., 2007; Magni et al., 2004), but also functions as a co-substrate for a number of non-redox enzymes (DNA ligase [Wilkinson et al., 2001], NAD+-dependent de-acetylase CobB/Sir-2 [Schmidt et al., 2004] and ADP-ribose transferase [Domenighini and Rappuoli, 1996]). The intra-cellular level of NAD+ is dependent on the de novo synthesis pathway and/or its salvage or recycling route (Gazzaniga et al., 2009). Unlike NAD+ synthesis in eukaryotes, which begins with tryptophan as a primer (Kurnasov et al., 2003), NAD+ in most prokaryotes is produced de novo from the amino acid aspartate (Kurnasov et al., 2003). Also, certain species have evolved salvage pathway to produce NAD+ (Figure 1) by recycling its precursor metabolites ranging from nicotinic acid (Na) (Boshoff et al., 2008) to nicotinamide (Nam) (Boshoff et al., 2008) and nicotinamide riboside (RNam) (Rodionov et al., 2008a; Kurnasov et al., 2002).
Tight regulation of NAD+ homeostasis is needed to prevent the accumulation of harmful intermediates (Huang et al., 2009). In fact, three types of regulatory systems have been described for NAD+ biosynthesis and/or salvage. In addition to the two well-known regulatory proteins (NadR [Gerasimova and Gelfand, 2005; Raffaelli et al., 1999] and NiaR [Rodionov et al., 2008a]), a family of Nudix-related transcriptional regulators (NrtR) was initially proposed via bioinformatics (Rodionov et al., 2008b) and recently validated in Streptococcus suis (Wang et al., 2019). The paradigm NadR protein of Enterobacteriaceae is unusual in that it has three different functional domains (Grose et al., 2005): i) the N-terminal transcriptional repressor domain (Grose et al., 2005; Penfound and Foster, 1999); the central domain of a weak adenylyltransferase (Raffaelli et al., 1999; Grose et al., 2005), and the C-terminal domain of nicotinamide ribose kinase (Kurnasov et al., 2002; Grose et al., 2005). NadR is a NAD+ liganded regulator (Penfound and Foster, 1999), whereas NiaR is a nicotinic acid-responsive repressor in most species of Bacillus and Clostridium (Rodionov et al., 2008a). Although the prototypic NrtR possesses dual functions (Nudix-like hydrolase and DNA-binding/repressor) (Huang et al., 2009; Rodionov et al., 2008b), the NrtR homolog in S. suis seems to be an evolutionarily remnant regulator that lacks enzymatic activity (Wang et al., 2019). The phylogeny of NrtR suggests that it is widely distributed across diversified species (Huang et al., 2009; Rodionov et al., 2008b; Wang et al., 2019), and that its regulation of central NAD+ metabolism contributes to the virulence of an opportunistic pathogen, Pseudomonas aeruginosa (Okon et al., 2017).
Mycobacterium tuberculosis is a successful pathogen in that it exploits flexible metabolism to establish persistent infection within the host, resulting in the disease of tuberculosis (TB) (Bi et al., 2011; Shiloh and Champion, 2010). Together with an alternative salvage route, the de novo synthesis of NAD+ balances NAD+ metabolism (Boshoff et al., 2008; Bi et al., 2011) (Figure 1). An earlier microbial study by Vilcheze et al. (2005) indicated that the removal of ndhII, a type II NADH dehydrogenase-encoding gene, increases the intracellular NADH/NAD+ ratio, which results in phenotypic resistance to both the front-line anti-TB drug isoniazid (INH) and the related drug ethionamide (ETH). Subsequently, the de novo and salvage pathways of NAD+ have been proposed as potential targets for anti-TB drugs (Vilchèze et al., 2010). Lysine acetylation is an evolutionarily conserved, reversible post-translational modification in three domains of life (Weinert et al., 2013). In general, the acetyl moiety is provided via two distinct mechanisms: i) Pat-catalyzed acetylation (Starai and Escalante-Semerena, 2004) and CobB-aided deacetylation (Starai et al., 2002) with acetyl-CoA as the donor of the acetyl group; and ii) the non-enzymatic action of acetyl-phosphate (AcP) donated by glycolysis (Kakuda et al., 1994; Klein et al., 2007). Not surprisingly, the lysine acetylation is linked to central metabolism via acetyl-CoA synthetase (Xu et al., 2011) and the biosynthesis of siderophore, an intracellular iron chelator (Vergnolle et al., 2016) in Mycobacterium. A universal stress protein (USP) is acetylated with the cAMP-dependent Pat acetyltransferase (MSMEG_5458) in M. smegmatis (Nambi et al., 2010). Nevertheless, it remains largely unclear i) how the de novo NAD+ synthesis is regulated and ii) whether or not such regulation is connected with acetylation in Mycobacterium. Here, we report that this is the case. We illustrate a regulatory circuit of NAD+ homeostasis by NrtR in the non-tuberculosis relative, M. smegmatis. More importantly, we elucidate that a post-translational modification of NrtR, acetylation of K134 in the non-enzymatic AcP manner, is a pre-requisite for its regulatory role. This might represent a common mechanism that balances the central NAD+ metabolism.
Results
Discovery of NrtR in the context of the NAD+ biosynthetic pathway
Genome context analyses suggested that the genes that encode the enzymes involved in the initial three steps of NAD+ synthesis (nadA/nadB/nadC) are organized in a conserved manner as an operon and located adjacent to a Nudix related transcriptional regulator (nrtR) on the chromosome of Mycobacterium species (Figure 1A). We identified a 23-bp NrtR-binding palindrome conservatively located between the nrtR and nadA/B/C operons in mycobacteria (Figure 1C). The sequence of the NrtR-binding motif in Mycobacterium species [5′-GTTTTCGA-N7-TCGAAAAC-3′] is significantly different from that in Streptococcus [5′-ATA-N-TTTA-N3-TAAAA-N2-ATA-3′] (Wang et al., 2019) (Figure 1B). This may reflect the fact that these two NrtR homologs are not functionally exchangeable. Therefore, we anticipate that NrtR regulates NAD+ de novo synthesis and coordinates it with the salvage pathway to maintain NAD+ homeostasis (Figure 1E). The most important clue is that de novo NAD+ synthesis is very conserved in different Mycobacterium species, enabling the use of Mycobacterium smegmatis as a model that can be used to study the regulatory mechanism for the de novo NAD+ synthesis pathway.
Phylogeny of NrtR
A maximum likelihood phylogenetic tree was constructed using 260 Nudix protein family representatives selected from diverse bacterial species (Figure 2A). The proteins carrying only a Nudix domain were removed, and 260 sequences coding for at least two protein domains were kept. Among these sequences, 38 with greater than 70% amino-acid identity were identified manually through literature mining and used for further analysis (Figure 2B). A common feature of the NrtR homologs is the invariant presence of the N-terminal Nudix domain (PF00293 or COG1051) fused with a characteristic C-terminal domain (PB002540), which is similar to the C-terminal part of proteins from the uncharacterized COG4111 family (Srouji et al., 2017). The data analyzed in this study suggest an evolutionary scenario for NrtR that includes the fusion of an ADPR-preferring Nudix hydrolase to a diversified DNA-binding domain. The phylogenetic groups found in this study show that these variable DNA-binding domains could result from the duplication of this domain and its subsequent substitution with a domain originating from a prototypical Nudix like Tlet_0901 in Thermotoga lettinagae (Zhaxybayeva et al., 2009). Moreover, some bacterial genomes encode many Nudix proteins. For example, two probable Nudix proteins were found in Mycobacterium (purple clade). Interestingly, these two homologs were distributed into different phylogenetic subgroups, indicating that they have distinct origins (Figure 2A).
Binding of M. smegmatis NrtR to cognate DNA
Using the NrtR-DNA complex (PDB: 3GZ6) as a template, structural modeling allowed us to probe the interaction of MsNrtR with its cognate DNA targets (Figure 3A). In total, six residues in its DNA-binding domain (namely D167, T169, N170, R173, K179, and R196) were predicted to be crucial for its DNA-binding ability (Figure 3A–B). Prior to biochemical analyses, the recombinant form of MsNrtR was purified to homogeneity (Figure 3—figure supplement 1A), and validated with both a chemical cross-linking assay (Figure 3—figure supplement 1B) and mass spectrometry (Figure 3—figure supplement 1C).
In our gel shift assays, the nrtR probe refers to a DNA fragment that contains a putative NrtR-recognizable palindrome [5′-GTTTTCGA-N7-TCGAAAAC-3′] (Figure 1C). The electrophoresis mobility shift assay (EMSA) confirmed that MsNrtR binds specifically to the nrtR probe (Figure 3C), rather than to an irrelevant DNA probe (such as the promoter of vprA, which encodes a response regulator of V. cholerae, Figure 3—figure supplement 2). This binding appears to be protein-dose-dependent (Figure 3C), which is consistent with the scenario suggested by the assay of surface plasmon resonance (SPR). In addition, SPR evaluated the binding affinity of MsNrtR to the cognate DNA probe (i.e., KD, the equilibrium dissociation constant, was around 1530 nM, Figure 3D). Then, six point-mutant versions of MsNrtR (D167A, T169A, N170A, R173A, K179A and R196A; Figure 3—figure supplement 3A–B) were also subjected to EMSA-based functional assays. In contrast to the wild-type protein (Figure 3—figure supplement 3C), each of these MsNrtR mutants (D167A [Figure 3—figure supplement 3D], T169A [Figure 3—figure supplement 3E], N170A [Figure 3—figure supplement 3F], R173A [Figure 3—figure supplement 3G], R196A [Figure 3—figure supplement 3H], and K179A [Figure 3—figure supplement 3I]) consistently lost their DNA-binding ability in our gel shift assays. Therefore, these six residues are indispensable for the efficient binding of MsNrtR to the cognate target gene.
ADP-ribose disrupts interplay between NrtR and DNA
MsNrtR is an ADP-ribose pyrophosphohydrolase that belongs to the Nudix hydrolase family. Multiple sequence alignment revealed that the Nudix motif of NrtR is less conserved than is the traditional Nudix hydrolase (Figure 3—figure supplement 4A). Consistent with this alignment, we could not detect any apparent ADPR pyrophosphohydrolase activity in the presence of Mg2+ or Mn2+ (Figure 3—figure supplement 4E). ADP-ribose is an intermediary metabolite that is produced by glycol-hydrolytic cleavage of NAD+ (Figure 1E), and it has been considered a highly reactive and potentially toxic molecule (Jacobson et al., 1994). Moreover, ADP-ribose is also a putative messenger in both eukaryotes and prokaryotes (Huang et al., 2009; Rodionov et al., 2008b; Li et al., 1998; Heiner et al., 2006). Although MsNrtR has lost its catalytic activity as an ADP-ribose pyrophosphohydrolase, we hypothesized that it retains an ability to interact with ADP-ribose. As expected, we observed that 50 mM of ADP-ribose can significantly release MsNrtR from DNA (Figure 3—figure supplement 5). Obviously, ADP-ribose is a ligand for the MsNrtR regulator.
In vivo role of MsNrtR in NAD+ synthesis
The results of PCR combined with reverse transcriptional PCR (RT-PCR) proved that the three adjacent genes nadA, nadB and nadC are transcribed in an operon (Figure 4A). Subsequently, real-time quantitative PCR (RT-qPCR) demonstrated that the removal of nrtR provides a 2- to 6-fold increase of the expression of the nadA/B/C operon compared with that in the WT (Figure 4B). In accordance with the qRT-PCR results (Figure 4B), the levels of intracellular NAD+ and NADH in the ΔnrtR mutant are higher than those in the WT, suggesting that NrtR acts as a repressor for homeostasis of the NAD+(NADH) pool (Figure 4C–D). To test whether or not NrtR is an auto-regulator, we fused a promoter-less LacZ to the nrtR promoter, giving the nrtR-lacZ transcriptional fusion (Figure 4—figure supplement 1A). Consequently, we found that deletion of nrtR causes a dramatic increase in the LacZ activity of nrtR-lacZ on agar plates (Figure 4—figure supplement 1A). Subsequently, we selected bacterial cultures at different growth stages (lag phase, log phase, and stationary phase, in Figure 4—figure supplement 1B) to compare the β-gal level of the nrtR promoter (Figure 4—figure supplement 1C–E). Intriguingly, the amplitude for auto-repression of nrtR is constantly around 8- to 10-fold, regardless of the growth stage of the bacteria (ranging from lag phase in Figure 4—figure supplement 1C and mid-log phase in Figure 4—figure supplement 1D, to equilibrium stage in Figure 4—figure supplement 1E). Thus, we concluded that the auto-repressor, NrtR, negatively regulates the expression of nadABC to maintain the homeostasis of the NAD+(NADH) pool in Mycobacterium.
Acetylation of K134 in MsNrtR
Unexpectedly, Western blotting elucidated that the recombinant MsNrtR is constantly acetylated, regardless of whether Escherichia coli or M. smegmatis was used as the expression host (Figure 5A). To further consolidate this observation, the MsNrtR protein was subjected to peptide mass fingerprinting through LC/MS (LTQ Orbitrap Elite) analysis. Of the five acetylated lysine sites that we identified, the Lys134 (K134) acetylation site is highly conserved in NrtR homologs from different species (Figure 5B and Figure 5—figure supplement 1A). Structural analysis suggested that K134 is located at the junction between the N-terminal Nudix domain and the C-terminal HTH domain (Figure 5B and Figure 5—figure supplement 1A). This is distinct from the other six residues that have direct contact with cognate DNA (Figure 3B and Figure 3—figure supplement 3B). In addition, it seems likely that acetylation of K134 is a prevalent form because the K134A mutant protein cannot be acetylated efficiently (Figure 5C). Moreover, Western blot assays informed us that acetylation is present in the NrtR paralogs of Vibrio and Streptococcus (other than Mycobacterium, Figure 5—figure supplement 2).
As an important post-translational modification of protein, acetylation can adjust protein activity (e.g., DNA-binding) by affecting protein charge (and/or its conformation) in E. coli (Castaño-Cerezo et al., 2014; Li et al., 2010) and Salmonella (Sang et al., 2016; Sang et al., 2017; Ren et al., 2016). This prompted us to investigate the physiological role of K134 acetylation in MsNrtR. To mimic the non-acetylated form, K134 of MsNrtR was designed to mutate into arginine (R), glutamine (Q), or alanine (A), giving three mutants of MsNrtR protein (K134A, K134Q, and K134R, Figure 5—figure supplement 1B). Similar to the wild-type of MsNrtR, all of the mutant proteins can be purified to homogeneity and eluted at the position of dimer in our gel filtration (Figure 5—figure supplement 1B). This ruled out the possibility that the acetylation of K134 associated with the dimeric configuration of MsNrtR. However, the EMSA experiments verified that the DNA-binding abilities of the aforementioned three protein mutants (K134R [Figure 5—figure supplement 1D], K134Q [Figure 5—figure supplement 1E] and K134A [Figure 5—figure supplement 1F]) are impaired to varying degrees when compared with their parental version (Figure 5—figure supplement 1C–G). This hints at a possibility that an acetylation of K134 might have a physiological role in NAD+ synthesis.
Dependence of non-enzymatic AcP in MsNrtR acetylation
In general, the reversible acetylation of MsNrtR falls into one of two categories: enzymatic action by the acetyltransferase Pat and a non-enzymatic acetyl phosphate (AcP)-dependent m (Figure 6A) (Ren et al., 2016; Ren et al., 2019). Of note, both of these processes can be reversed by the deacetylase CobB (Figure 6A) (Ren et al., 2016; Ren et al., 2019). To address possible origin of K134 acetylation, we integrated an in vitro chemical assay and a genetic exploration in vivo (Figure 6B–I). To test the relevance of K134 acetylation to the enzymatic action of Pat/CobB, we deleted the pat (MSMEG_5458)/cobB (MSMEG_5175) gene (Figure 6A) from M. smegmatis by homologous recombination. As expected, the USP (universal stress protein, MSMEG_4207) is validated as the positive control that requires Pat for its enzymatic acetylation (Figure 6B). By contrast, we detected no difference in the acetylation levels of the MsNrtR proteins of WT, Δpat and ΔcobB (Figure 6C). This might rule out the possibility of Pat-catalyzed acetylation of MsNrtR. Then, we wondered whether or not K134 acetylation of MsNrtR proceeds via AcP-dependent route (Figure 6D–I). First, we established an in vitro system in which MsNrtR was incubated with AcP (Figure 6D–E), an intermediate product of glycolysis (Figure 6J). This showed clearly that the percentage of acetylated NrtR increased in a time-dependent manner (Figure 6D and F). This acetylation also occurred in an AcP-dose-dependent manner (Figure 6E and G). Obviously, these findings constitute in vitro evidence that AcP donates the acetyl group for the post-translational acetylation of NrtR (Figure 6D–G). Second, we secured in vivo evidence by knocking-out the AcP-pathway-encoding genes ackA and pta (Figure 6A and J). The acetylation level of MsNrtR in the double mutant of M. smegmatis (ΔackA+Δpta), is reduced 4–5-fold when compared with its parental strain (Figure 6H–I). This finding is similar to those of Weinert et al. (2013) working on NrtR acetylation in E. coli under different growth conditions (induced with glucose or acetate). In M. smegmatis, the removal of a single ackA only slightly repressed the acetylation of MsNrtR growing under inducing conditions of either 0.2% glucose or 1.0% acetate (Figure 6H–I). Along with the in vitro data, the in vivo evidence allowed us to conclude that the K134 acetylation of MsNrtR is physiologically dependent on the AckA/Pta-containing route for AcP formation (Figure 6J).
Physiological roles of K134 acetylation
To further investigate the in vivo role of K134 acetylation in the regulatory function of NrtR (Figure 7), we engineered M. smegmatis mutants carrying point-mutations of K134 (namely K134A, K134Q, and K134R) on chromosomal nrtR (Figure 5—figure supplement 3A–C). All the point-mutants of K134 were confirmed with direct DNA sequencing (Figure 5—figure supplement 3C). Also, Western blot was applied to prove that the mutated proteins are well expressed in vivo (Figure 5—figure supplement 3D). As expected, the removal of nrtR (positive control) gave around a ten-fold increase in the β-gal level of nrtR-lacZ transcriptional fusion (Figure 7A). In general agreement with the positive control, the K134Q mutation led to a three-fold upregulation in nrtR transcription (Figure 7A), Similar scenarios were also observed for the other two point-mutants, K134A and K134R, despite the lower level of (close to two-fold) of regulatory dysfunction in the control of nrtR transcription (Figure 7A). RT-qPCR assays showed that functional impairment of the K134 acetylation site can increase the transcriptional level of the nadABC operon 2–3-fold (Figure 7B). More importantly, the pool of intra-cellular NAD+ in the K134 point-mutants accumulated to a level that was 2–3-fold that in the wild-type strain (Figure 7C). A similar observation occurs with NADH (Figure 7D).
Given that i) the K134 acetylation of NrtR involves the control of the cytosolic NAD+ pool (Figure 7) and ii) the acetylation of NrtR is AcP-dependent (Figure 6), we hypothesized that the AckA/Pta-including AcP pathway contributes to the NrtR-mediated regulation of the cytosolic NAD+ pool (Figure 8A). As anticipated, inactivation of the AcP pathway (especially in the Δpta+ΔackA double mutan having AcP level of ~10 μM, largely lower than that of the parental strain, ~460 μM) led to a significant increase in the β-gal level of nrtR-lacZ transcriptional fusion (Figure 8B). In particular, the cytosolic pools of both NAD+ (Figure 8C) and NADH (Figure 8D) were increased 2.5–3-fold in the double mutant (Δpta+ΔackA), which is deficient in the AcP pathway. Therefore, the data suggest that the AcP-dependent acetylation of K134 is necessary for NrtR to regulate the homeostasis of NAD+ in Mycobacterium.
Discussion
It has been estimated that 17% of the enzymes of central metabolism that are essential for the survival of M. tuberculosis require the NAD+ cofactor (Beste et al., 2007), regardless of the organism's state of latency or active-replication (Rodionova et al., 2014). It is rational that the NAD+ metabolic pathway and its regulatory mechanism have been recognized as an attractive target for the development of new anti-TB therapeutics (Rodionova et al., 2014). Although NrtR, as the third regulator of NAD+ metabolism (Rodionov et al., 2008b), has been described in vitro in different species such as Shewanella (Huang et al., 2009), the data we show here provide the first relatively full picture of the regulatory circuits of NAD+ synthesis involving NrtR, an evolutionarily distinct regulator, in a non-pathogenic M. smegmatis (Figure 1). Although it structurally comprises an N-terminal Nudix domain and a C-terminal Helix-Turn-Helix motif (Huang et al., 2009), MsNrtR retains only the ability to bind cognate DNA (Figure 3) and loses its ADP-ribose hydrolase activity (Figure 3—figure supplement 3). There are mutations at three residues (GX5EX7RQUXEKXDU) (Carreras-Puigvert et al., 2017) in the Nudix motif of MsNrtR that we attempted to reverse, but we were unable to recover the enzymatic function of the protein (Figure 3—figure supplement 4). It seems likely that natural selection/evolution has rendered the hydrolyzing ADP-ribose NrtR inactive in order to avoid functional redundancy. This prediction is in part (if not entirely) explained by the genome-wide distribution of 29 predicted proteins of the Nudix hydrolase family in M. smegmatis (Supplementary file 3).
A similar scenario in which the S. suis NrtR has an inactive Nudix hydrolase domain (Wang et al., 2019) allowed us to further hypothesize that most members of the Nudix-related regulator family might initially recruit ancient Nudix hydrolase as a signaling module, and then un-necessitate its enzymatic function while retaining its regulatory role as an evolutionary relic (Wang et al., 2019). The diversity of genomic organization of nrtR and its neighboring regulatory loci highlights that this gene is being subjected to dynamic domestication (Rodionov et al., 2008b). Evidently, the nrtR is integrated into the ‘nadR-pnuC-nrtR’ cluster in the human pathogen S. suis 2, assuring a regulated salvage/recycling pathway (Rodionov et al., 2008b; Wang et al., 2019). By contrast, the nrtR on the opposite strand is adjacent to an operon of nadA/B/C (the intergenic region of which contains a NrtR-recognizable site; Figures 1A and 4A), guaranteeing the control of de novo NAD+ synthesis (Figure 1D–E). Indeed, the NrtR is somewhat promiscuous because it modulates xylose (e.g., xylBAT of Bacteroides) and arabinose (e.g., araBDA of Flavabacterium) utilization in rare microorganisms (Rodionov et al., 2008b). Consistent with earlier descriptions (Rodionov et al., 2008b), the NrtR orthologs of S. suis (Wang et al., 2019) and M. smegmatis (Figure 3—figure supplement 5) proved to be antagonized by ADP-ribose in the binding to cognate DNA targets. By contrast, the NrtR (also named NdnR) of Corynebacterium glutamicum, a close relative of Mycobacterium, has surprisingly been found to exhibit more affinity to binding the DNA probe in the presence of NAD+ (Teramoto et al., 2012). This is probably explained by the varied configuration of signaling module within different NrtR orthologs. Because the NrtR of Pseudomonas participates in the fitness and virulence of this pathogen within mice (Okon et al., 2017), it is very interesting to wonder how NrtR and its regulated route of NAD+ synthesis contribute to the survival and chronic infection of Mycobacterium within the host environment.
Protein acetylation is a ubiquitous form of post-translational modification in prokaryotes (Ren et al., 2017), which is implicated in central metabolism and even bacterial pathogenicity (Ren et al., 2019; Sang et al., 2016). A global acetylome analysis of M. tuberculosis by Ge and coworkers (Liu et al., 2014) identified almost 137 unique acetylated proteins that are involved in diverse biological processes, some of which had undergone lysine acetylation. In this study, we are first to discover the lysine acetylation (K134) at the junction between the N-terminal Nudix domain and the C-terminal wHTH domain of MsNrtR (Figure 5). It is unusual, but not without any precedent. In fact, our research group very recently affirmed the presences of such a modification of K47 in the M. smegmatis BioQ that regulates biotin metabolism (Tang et al., 2014; Wei et al., 2018). Given that K134 is conserved in NrtR orthologs of different origins (Figure 7—figure supplement 1A), we hypothesized that it is a common hallmark for NrtR. However, this requires further experimental demonstration. Evidently, it is likely that a single lysine acetylation maintains the pools of two distinct cofactors (biotin and NAD+) by modifying a certain regulator. In light of the facts that i) mycobacterial NAD+ metabolism is regarded as an promising drug target (Bi et al., 2011; Rodionova et al., 2014) and ii) the synthesis and utilization of biotin is necessary for survival and infectivity of intracellular pathogens (Park et al., 2015; Bockman et al., 2015; Woong Park et al., 2011), we hypothesized that lysine acetylation plays an indispensable role in bacterial virulence. This is generally consistent with the K201 acetylation of PhoP, a response regulator of the two-component system in Salmonella virulence (Ren et al., 2016; Ren et al., 2019). Given that the acetylation of NrtR paralogs is also detected in two additional pathogenic species, the Gram-negative V. cholerae and Gram-positive S. suis (Figure 5—figure supplement 2), it is possible that the lysine acetylation of NrtR represents an evolutionarily conserved mechanism by which a group of pathogens develop successful infections within the nutrition-limited tough host niche.
In summary, the functional definition of K134 acetylation in MsNrtR updates our understanding of the homeostasis of NAD+, an indispensable coenzyme. This evidence provides an alternative paradigm for the development of anti-TB virulence lead drugs that can impair crosstalk between the nutritional/restricted virulence factor (NAD+) and NrtR by disrupting the acetylation-requiring regulatory system (Figure 8A).
Materials and methods
Bacterial strains, plasmids and growth conditions
Request a detailed protocolThe bacterial species used in this study include E. coli and M. smegmatis (Supplementary file 1). Strains were cultured as described previously (Tang et al., 2014; Wei et al., 2018). pET28a-nrtR and pMV261-nrtR were constructed as follows. nrtR was cloned into the pET-28a expression vector between BamHI and XbaI restriction sites. The resulting plasmid contained the nrtR gene fused to a hexahistidine-tag sequence at the N-terminus and was transformed into E. coli BL21(DE3) for heterologous expression of NrtR. The mycobacterial expression plasmid pMV261-nrtR was constructed by cloning the nrtR gene fused to a His-tag sequence at the C-terminus via BamHI and SalI sites. This recombinant plasmid was then electro-transformed into M. smegmatis MC2 155 (Magni et al., 2004) for endogenous production of NrtR. Overlap PCR was utilized for site-directed mutagenesis of the nrtR gene using specific primers (Supplementary file 2).
Protein expression, purification and identification
Request a detailed protocolWild-type MsNrtR and its point mutants were overexpressed in E. coli or M. smegmatis MC2 155 (Magni et al., 2004). The expression of proteins in E. coli (BL21) was induced by the addition of 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) (Gao et al., 2017). For protein purification, the cells were harvested by centrifugation and lysed by sonication. The clarified lysate was loaded onto a Ni-nitrilotriacetic acid (Ni-NTA) column (Qiagen) and eluted with 150 mM imidazole (Gao et al., 2017). The protein preparation was further purified by gel filtration through a Superdex 75 10/300 column (GL, GE Healthcare) and the protein purity was judged with 12% SDS-PAGE.
The recombinant MsNrtR expressed in E. coli and M. smegmatis was separated by SDS-PAGE gel and subjected to peptide mass fingerprinting with Liquid Chromatography (LC)-mass spectrometry (MS) (Wei et al., 2018; Gao et al., 2016a). The resultant polypeptides were separated by the EASY-nLC HPLC system (Thermo Scientific, USA) and detected using a Thermo Fisher LTQ orbitrap elite mass spectrometer (Thermo Scientific, USA). The MS spectrum containing the possible site of acetylation was detected and assigned by Mascot 2.2 (Ren et al., 2016). To further visualize the solution structure, 6 × His tagged MsNrtR protein was subjected to chemical cross-linking assays with the cross-linker of ethylene glycol bis-succinimidylsuccinate (Pierce) as we earlier described (Feng and Cronan, 2010).
Electrophoretic mobility shift assays
Request a detailed protocolThe interaction of MsNrtR with its DNA target was specified by gel shift assay (Gao et al., 2017). The DNA probe containing an MsNrtR-recognizable palindrome (designated nrtR) was generated by annealing two complementary primers (nrtR-probe-F and nrtR-probe-R) in TEN buffer (10 mM Tris-HCl, 1 mM EDTA, 100 mM NaCl [pH 8.0]) (Gao et al., 2016b). The DNA probe was mixed with purified NrtR protein in EMSA buffer (50 mM Tris-HCl [pH 7.5]; 10 mM MgCl2; 1 mM DDT; 100 mM NaCl) and incubated at room temperature for about 30 min (Wei et al., 2018). The DNA–protein complexes were separated on native 8% native polyacrylamide gels, and the shifted DNA bands were visualized by staining with ethidium bromide (EB) (Gao et al., 2017).
Surface plasmon resonance
Request a detailed protocolTo evaluate the parameters of binding between NrtR and its DNA target, surface plasmon resonance (SPR) was employed using a Biacore3000 instrument (GE Healthcare) at 25°C. A biotinylated nrtR probe was injected onto the flow cells of a SA sensor chip at a flow rate of 10 μl/min until the calculated amount of DNA had been bound, giving a 34 RU maximum. All of the SPR experiments were conducted in the running buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl and 0.005% (v/v) Tween 20) at a flow rate of 30 μl/min (Gao et al., 2017). A series of dilutions of protein samples were injected and passed over the chip surface for 2 min. The dissociation phase was followed for 3 min in the same buffer, and the surface was then regenerated with 0.025% SDS for 24 s. Kinetic parameters were analyzed using a global data analysis program (BIA evaluation software).
Assays for β-gal activity
Request a detailed protocolTranscriptional levels were measured using lacZ transcriptional fusions carried on plasmid pMV261 in M. smegmatis (WT and ΔnrtR). Cells from log-phase cultures grown in LB broth containing 0.2% glycerol, 0.05% Tween-80, and 50 μg/ml kanamycin were collected by centrifugation, washed twice with RB medium supplemented with 0.05% Tween-80. and re-suspended in Z-buffer for measurement of β-gal activity (Miller, 1992; Feng and Cronan, 2009a; Feng and Cronan, 2009b). Data were obtained from three independent trials and presented as a means and standard deviations (SD).
Generation of chromosomal knock-out and knock-in strains
Request a detailed protocolThe knock-out and knock-in strains of the M. smegmatis nrtR (MSMEG_3198) gene were generated using the homologous recombination method as described before (Tang et al., 2014; Yang et al., 2012). A suicide plasmid was constructed by cloning the knock-out or knock-in fusion PCR products (Supplementary file 1) into pMind between NheI and PacI, followed by the insertion of a sacB-lacZ cassette as a selection marker at the PacI site (Supplementary file 1). The recombinant plasmid was electroporated into competent cells of M. smegmatis (wild-type or nrtR deletion mutant) and plated on LB medium containing 100 μg/ml X-gal and 50 mg/L kanamycin for screening of single-crossover mutant strains. Single colonies were picked and inoculated into kanamycin-free LB broth, 37°C, 220 rpm for 24 hr. The incubated culture was plated on LB medium containing 100 μg/ml X-gal and 10% sucrose. The white colonies representing allelic-exchange mutants were picked and identified by multiplex-PCR and direct DNA sequencing. The mutants of M. smegmatis include an in-frame deletion mutant (ΔnrtR) and three point-mutants of K134 on the chromosomal nrtR (namely K134A, K134R, and K134Q, in Supplementary file 1). A similar approach was applied to delete the four acetylation pathway genes in M. smegmatis, namely pat (MSMEG_5458), cobB (MSMEG_5175), ackA (MSMEG_0784), and pta (MSMEG_0783). The resultant mutants denote three single mutants (Δpat, ΔcobB, and ΔackA) and a double mutant (ΔackA+Δpta) (Supplementary file 1).
Western blot
Request a detailed protocolPolyclonal anti-serum against MsNrtR was generated by immunizing a rabbit with purified MsNrtR as shown recently (Gao et al., 2017). The specificity and sensitivity of the acquired polyclonal antibody was evaluated by western blot and ELISA with pre-immune sera used as a negative control. Subsequently, western blot was conducted routinely (Gao et al., 2017). To probe the possible acetylation of the MsNrtR, the anti-acetyl-lysine antibody (Abcam, ab61257) acted as primary antibody. To normalize the relative level of NrtR acetylation, the NrtR concentrations were measured with western blot in which an anti-MsNrtR polyclonal serum was introduced as a primary antibody, as described recently but with minor alteration (Ren et al., 2016).
Non-enzymatic acetylation of NrtR in vitro
Request a detailed protocolThe MsNrtR protein (10 μg) was incubated with different concentrations of acetyl phosphate (AcP) in Tris-HCl buffer (50 mM [pH 8.0] containing NaCl (150 mM) at 37°C for 2 hr; Weinert et al., 2013; Wang et al., 2017). Following the separation of the reaction mixture by SDS-PAGE (12%), the acetylated form of MsNrtR protein was detected using western blot with an anti-acetyl-lysine antibody (Abcam, ab61257).
Determination of intracellular NAD+ and NADH concentrations
Request a detailed protocolPrior to the quantification of the bacterial NAD+/NADH pool, cell counts per optical density at wavelength 600 (OD600) were determined via bacterial plating. In brief, the log-phase cultures of M. smegmatis (wild-type and its mutants) were adjusted to OD600 of 1.0, and serially diluted in 105-folds with fresh 7H9 broth. The resultant bacterial suspension (100 μl) was plated on LB medium, and kept for around three days at 37°C. Finally, colony counting (each at OD600) was determined to be about 1.0 × 108 CFU/ml (Figure 7—figure supplement 1). The intracellular level of both NAD+ and NADH was determined using a NAD+/NADH kit (Sino Best Biological Technology). Wild-type and mutant strains were collected when their OD600 reached around 1.0 (about 1.0 × 108 CFU/ml, in Figure 7—figure supplement 1). Aliquots of bacterial cultures (2–4 ml) were harvested by centrifugation at 4°C for 10 min at 4000 rpm. After discarding the supernatant, the bacterial pellets were washed twice with 1 ml fresh 7H9 medium. Then NAD+ and NADH concentrations in bacterial pellets were extracted and calculated as recommended by the manufacturer.
RNA isolation, RT-PCR and real-time quantitative RT-PCR
Request a detailed protocolMid-log phase cultures of M. smegmatis and its mutants grown in LB media or 7H9 media were collected for total bacterial RNA preparations. TRIzol reagent (Life Technologies) was used to isolate total RNA. The RNA quality was detected to avoid trace genomic DNA contamination (Feng and Cronan, 2010; Feng and Cronan, 2009b). First-strand cDNAs were synthesized using a PrimeScript RT reagent Kit with gDNA Eraser (Takara). The final cDNAs were diluted and served as the template for PCR amplification of the nad operon-related DNA fragments using specific primers (Supplementary file 2). Real-time PCR analysis was performed using SYBR Green Master Mix Reagent (Takara). The 16S rDNA gene served as internal reference and the relative expression levels were calculated using the 2-∆∆CT method (Livak and Schmittgen, 2001).
Enzymatic assays
Request a detailed protocolThe Nudix hydrolase activities of NrtR and NrtRQ54E&K58E&D60E were purified to homogeneity. The reaction mixture (150 μl) contained 50 mM HEPES (pH 8.2), together with either 5 mM MgCl2 or 0.2 mM ADP-ribose and an appropriate amount of NrtR_ms or NrtRQ54E&K58E&D60E. After 30 min incubation at 37°C, the reaction was stopped by adding 75 μl of cold 1.2 M HClO4. Reaction products were assayed using HPLC with a column (DiKMA C18-T, 4.6 × 250 mm, 5 μm particle size) at 16°C. The elution conditions were the same as those used before (Wang et al., 2019).
Phylogenetic analysis
Request a detailed protocolNrtR proteins were collated from Vibrio cholerae, Mycobacterium smegmatis and Streptococcus suis. BLASTp (Johnson et al., 2008) was used to identify homologs with identity 30% and coverage 30% as cut-offs. 750 homologs of NrtR were found and manually curated in the 9434 RefSeq-archived genomes as of April, 2018, including bacterial and archaeal sequences. To verify the Nudix domain in these homologs, the Protein Families database (Pfam, available at pfam.xfam.org) and the Clusters of Orthologous Groups (COG, available at ncbi.nlm.nih.gov/COG) database were used to identify conserved functional domains (Tatusov et al., 2000). Next, protein homologs were further filtered by examining their conserved domain. The proteins carrying only the Nudix domain were removed, and 260 sequences coding for at least two protein domains were kept (Unrooted phylogeny). Subsequently, 38 sequences were further analyzed on the basis of 70% identity at amino-acid sequence level by manual collation (Hierarchical tree). Multiple sequence alignments of protein sequences were produced by the Clustal W program (Chenna et al., 2003). The MEGA software was used for construction of a maximum likelihood phylogenetic tree for the NrtR protein family, including bootstrapping with 1000 replicates and drawing of a consensus tree. The number of the corresponding phylogenetic clade reflects the putative evolutionary distance for each node.
Bioinformatics
Request a detailed protocolThe protein sequences of MsNrtR and its homologs from different species were aligned by Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/), and the final output of the multiple sequence alignments was given processed by the program ESPript 2.2 http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi). Structural modeling for the MsNrtR-DNA was processed using Swiss-Model with SoNrtR-DNA as a structural template (PDB: 3GZ6). The resultant result was given in ribbon structure via PyMol (https://pymol.org/2).
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files.
References
-
NAD+ metabolism in health and diseaseTrends in Biochemical Sciences 32:12–19.https://doi.org/10.1016/j.tibs.2006.11.006
-
Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targetsJournal of Cellular Physiology 226:331–340.https://doi.org/10.1002/jcp.22419
-
Targeting Mycobacterium tuberculosis biotin protein ligase (MtBPL) with nucleoside-based bisubstrate adenylation inhibitorsJournal of Medicinal Chemistry 58:7349–7369.https://doi.org/10.1021/acs.jmedchem.5b00719
-
Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosisJournal of Biological Chemistry 283:19329–19341.https://doi.org/10.1074/jbc.M800694200
-
Multiple sequence alignment with the clustal series of programsNucleic Acids Research 31:3497–3500.https://doi.org/10.1093/nar/gkg500
-
Escherichia coli unsaturated fatty acid synthesis: complex transcription of the fabA gene and in vivo identification of the essential reaction catalyzed by FabBThe Journal of Biological Chemistry 284:29526–29535.https://doi.org/10.1074/jbc.M109.023440
-
A new member of the Escherichia coli fad regulon: transcriptional regulation of fadM (ybaW)Journal of Bacteriology 191:6320–6328.https://doi.org/10.1128/JB.00835-09
-
Overlapping repressor binding sites result in additive regulation of Escherichia coli FadH by FadR and ArcAJournal of Bacteriology 192:4289–4299.https://doi.org/10.1128/JB.00516-10
-
Transcriptional repression of the VC2105 protein by Vibrio FadR suggests that it is a new auxiliary member of the fad regulonApplied and Environmental Microbiology 82:2819–2832.https://doi.org/10.1128/AEM.00293-16
-
Structural and functional characterization of the FadR regulatory protein from Vibrio alginolyticusFrontiers in Cellular and Infection Microbiology 7:513.https://doi.org/10.3389/fcimb.2017.00513
-
Microbial NAD metabolism: lessons from comparative genomicsMicrobiology and Molecular Biology Reviews 73:529–541.https://doi.org/10.1128/MMBR.00042-08
-
Evolution of the nadR regulon in EnterobacteriaceaeJournal of Bioinformatics and Computational Biology 03:1007–1019.https://doi.org/10.1142/S0219720005001387
-
Regulation of NAD synthesis by the trifunctional NadR protein of Salmonella entericaJournal of Bacteriology 187:2774–2782.https://doi.org/10.1128/JB.187.8.2774-2782.2005
-
Glycation of proteins by ADP-riboseMolecular and Cellular Biochemistry 138:207–212.https://doi.org/10.1007/BF00928463
-
NCBI BLAST: a better web interfaceNucleic Acids Research 36:W5–W9.https://doi.org/10.1093/nar/gkn201
-
Regulation of K(Ca)-channel activity by cyclic ADP-ribose and ADP-ribose in coronary arterial smooth muscleThe American Journal of Physiology 275:H1002–H1010.https://doi.org/10.1152/ajpheart.1998.275.3.H1002
-
CobB regulates Escherichia coli chemotaxis by deacetylating the response regulator CheYMolecular Microbiology 76:1162–1174.https://doi.org/10.1111/j.1365-2958.2010.07125.x
-
Acetylome analysis reveals diverse functions of lysine acetylation in Mycobacterium tuberculosisMolecular & Cellular Proteomics 13:3352–3366.https://doi.org/10.1074/mcp.M114.041962
-
Enzymology of NAD+ homeostasis in manCellular and Molecular Life Sciences 61:19–34.https://doi.org/10.1007/s00018-003-3161-1
-
cAMP-regulated protein lysine acetylases in mycobacteriaJournal of Biological Chemistry 285:24313–24323.https://doi.org/10.1074/jbc.M110.118398
-
Key role of an ADP-ribose-dependent transcriptional regulator of NAD metabolism for fitness and virulence of Pseudomonas aeruginosaInternational Journal of Medical Microbiology 307:83–94.https://doi.org/10.1016/j.ijmm.2016.09.007
-
NAD-dependent DNA-binding activity of the bifunctional NadR regulator of Salmonella typhimuriumJournal of Bacteriology 181:648–655.
-
The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activityJournal of Bacteriology 181:5509–5511.
-
Protein acetylation and its role in bacterial virulenceTrends in Microbiology 25:768–779.https://doi.org/10.1016/j.tim.2017.04.001
-
Metabolic intermediate acetyl phosphate modulates bacterial virulence via acetylationEmerging Microbes & Infections 8:55–69.https://doi.org/10.1080/22221751.2018.1558963
-
Deciphering key features in protein structures with the new ENDscript serverNucleic Acids Research 42:W320–W324.https://doi.org/10.1093/nar/gku316
-
Transcriptional regulation of NAD metabolism in Bacteria: genomic reconstruction of NiaR (YrxA) regulonNucleic Acids Research 36:2032–2046.https://doi.org/10.1093/nar/gkn046
-
Transcriptional regulation of NAD metabolism in Bacteria: NrtR family of Nudix-related regulatorsNucleic Acids Research 36:2047–2059.https://doi.org/10.1093/nar/gkn047
-
Protein acetylation is involved in Salmonella enterica Serovar Typhimurium VirulenceJournal of Infectious Diseases 213:1836–1845.https://doi.org/10.1093/infdis/jiw028
-
Acetylation regulating protein stability and DNA-binding ability of HilD, thus modulating Salmonella Typhimurium virulenceThe Journal of Infectious Diseases 216:1018–1026.https://doi.org/10.1093/infdis/jix102
-
Coenzyme specificity of Sir2 protein deacetylases: implications for physiological regulationThe Journal of Biological Chemistry 279:40122–40129.https://doi.org/10.1074/jbc.M407484200
-
To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?Current Opinion in Microbiology 13:86–92.https://doi.org/10.1016/j.mib.2009.11.006
-
The evolution of function within the nudix homology clanProteins: Structure, Function, and Bioinformatics 85:775–811.https://doi.org/10.1002/prot.25223
-
Identification of the protein acetyltransferase (Pat) enzyme that acetylates acetyl-CoA synthetase in Salmonella entericaJournal of Molecular Biology 340:1005–1012.https://doi.org/10.1016/j.jmb.2004.05.010
-
Mycobacterium smegmatis BioQ defines a new regulatory network for biotin metabolismMolecular Microbiology 94:1006–1023.https://doi.org/10.1111/mmi.12817
-
The COG database: a tool for genome-scale analysis of protein functions and evolutionNucleic Acids Research 28:33–36.https://doi.org/10.1093/nar/28.1.33
-
Post-translational acetylation of MbtA modulates mycobacterial siderophore biosynthesisJournal of Biological Chemistry 291:22315–22326.https://doi.org/10.1074/jbc.M116.744532
-
Altered NADH/NAD+ratio mediates coresistance to isoniazid and ethionamide in mycobacteriaAntimicrobial Agents and Chemotherapy 49:708–720.https://doi.org/10.1128/AAC.49.2.708-720.2005
-
NAD+ auxotrophy is bacteriocidal for the tubercle bacilliMolecular Microbiology 76:365–377.https://doi.org/10.1111/j.1365-2958.2010.07099.x
-
Bacterial DNA ligasesMolecular Microbiology 40:1241–1248.https://doi.org/10.1046/j.1365-2958.2001.02479.x
-
A TetR-like regulator broadly affects the expressions of diverse genes in Mycobacterium smegmatisNucleic Acids Research 40:1009–1020.https://doi.org/10.1093/nar/gkr830
Article and author information
Author details
Funding
National Natural Science Foundation of China (31830001)
- Youjun Feng
National Natural Science Foundation of China (81772142)
- Youjun Feng
National Natural Science Foundation of China (31570027)
- Youjun Feng
Ministry of Science and Technology of the People's Republic of China (2017YFD0500202)
- Youjun Feng
Thousand Talents Plan
- Youjun Feng
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (31830001, 81772142 and 31570027, YF) and the National Key R & D Program of China (2017YFD0500202, YF). Dr Feng is a recipient of the national ‘Young 1000 Talents’ Award of China.
Copyright
© 2019, Gao et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,069
- views
-
- 384
- downloads
-
- 14
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
Malaria parasites have evolved unusual metabolic adaptations that specialize them for growth within heme-rich human erythrocytes. During blood-stage infection, Plasmodium falciparum parasites internalize and digest abundant host hemoglobin within the digestive vacuole. This massive catabolic process generates copious free heme, most of which is biomineralized into inert hemozoin. Parasites also express a divergent heme oxygenase (HO)-like protein (PfHO) that lacks key active-site residues and has lost canonical HO activity. The cellular role of this unusual protein that underpins its retention by parasites has been unknown. To unravel PfHO function, we first determined a 2.8 Å-resolution X-ray structure that revealed a highly α-helical fold indicative of distant HO homology. Localization studies unveiled PfHO targeting to the apicoplast organelle, where it is imported and undergoes N-terminal processing but retains most of the electropositive transit peptide. We observed that conditional knockdown of PfHO was lethal to parasites, which died from defective apicoplast biogenesis and impaired isoprenoid-precursor synthesis. Complementation and molecular-interaction studies revealed an essential role for the electropositive N-terminus of PfHO, which selectively associates with the apicoplast genome and enzymes involved in nucleic acid metabolism and gene expression. PfHO knockdown resulted in a specific deficiency in levels of apicoplast-encoded RNA but not DNA. These studies reveal an essential function for PfHO in apicoplast maintenance and suggest that Plasmodium repurposed the conserved HO scaffold from its canonical heme-degrading function in the ancestral chloroplast to fulfill a critical adaptive role in organelle gene expression.
-
- Computational and Systems Biology
- Microbiology and Infectious Disease
Bacterial membranes are complex and dynamic, arising from an array of evolutionary pressures. One enzyme that alters membrane compositions through covalent lipid modification is MprF. We recently identified that Streptococcus agalactiae MprF synthesizes lysyl-phosphatidylglycerol (Lys-PG) from anionic PG, and a novel cationic lipid, lysyl-glucosyl-diacylglycerol (Lys-Glc-DAG), from neutral glycolipid Glc-DAG. This unexpected result prompted us to investigate whether Lys-Glc-DAG occurs in other MprF-containing bacteria, and whether other novel MprF products exist. Here, we studied protein sequence features determining MprF substrate specificity. First, pairwise analyses identified several streptococcal MprFs synthesizing Lys-Glc-DAG. Second, a restricted Boltzmann machine-guided approach led us to discover an entirely new substrate for MprF in Enterococcus, diglucosyl-diacylglycerol (Glc2-DAG), and an expanded set of organisms that modify glycolipid substrates using MprF. Overall, we combined the wealth of available sequence data with machine learning to model evolutionary constraints on MprF sequences across the bacterial domain, thereby identifying a novel cationic lipid.